UK – Epoch Biodesign, a London, UK-based Total BioDesignTM Company, raised $11M in seed funding.
The round was led by Lowercarbon Capital, with participation from BoxGroup, Amadeus Capital Partners, MCJ Collective, Zero Carbon capital, VOYAGERS Climate-Tech Fund, The Venture Collective, and more. The company intends to use the funds for the expansion of its protein design platform, construction of new R&D facilities and further development and scale up of their first solution.Led by CEO Jacob Nathan, Epoch Biodesign is a company developing natural solutions for unnatural problems with the mission to scale and industrialize biology for a healthy planet. With a combination of proprietary computational and experimental tools, Epoch is advancing biorecycling: a tuneable enzymatic process to transform plastic waste into everyday chemicals.22/06/2022About Epoch Biodesign
